טוען...
Donor: Recipient ABO mismatch does not impact outcomes of allogeneic hematopoietic cell transplantation regardless of graft source
The impact of ABO mismatch has been studied on various hematopoietic cell transplant (HCT) outcomes including neutrophil and platelet engraftment, pure red cell aplasia (PRCA), acute and chronic GVHD, non-relapse mortality (NRM) and overall survival (OS). Yet conflicting results have been reported....
שמור ב:
| הוצא לאור ב: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5744261/ https://ncbi.nlm.nih.gov/pubmed/28232088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.02.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|